Ferritin levels were used to monitor the activity of the hemophagocytic syndrome. After initiation of weekly infliximab, guided by TNF-a levels, the ferritin level remained low with clinical improvement. A trial of tapering the infliximab and etoposide resulted in a relapse of symptoms and a sharp rise in ferritin level.